GlobalMed acquires ORCAS to bring Care Management R&D and mobile self-management interventions to clinical telemedicine.Continue reading
Category Archives: AZBio News
GlobalMed Welcomes 2017 on the Heels of Strong 2016 Performance
A record third quarter in 2016, topped by a record fourth quarter, signals strong demand continuing for GlobalMed telemedicine solutions.Continue reading
Diagnostics goes digital with technology conceived at ASU
Innovation is part of $400 million international Digital Life Alliance aimed at producing a personalized health guideContinue reading
Finding the Needle in a Genomic Haystack
Sequencing reveals mutation in brain protein as cause of boy’s physical and cognitive impairmentsContinue reading
Understanding Gov. Ducey’s $1 billion university research infrastructure plan
Building on Success for a Better Arizona – Your Letter Can Make a Difference – Click Here to Learn More
Freshman AZ Congressman Signs on to Support Medical Device Tax Repeal
U.S. Representative Tom O’Halleran of Arizona’s 1st Congressional District is one of eighteen Freshman Congressmen who have signed on to a letter asking House Speaker Paul Ryan to consider fast-tracking consideration of H.R. 184, Protect Medical Innovation Act.Continue reading
NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. Sign Licensing Agreement for Hemorrhagic Shock and Perioperative Blood Loss
NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. Sign Licensing Agreement for Hemorrhagic Shock and Perioperative Blood Loss
Lurie Children’s Patient is Youngest, Smallest to Receive 50cc SynCardia Total Artificial Heart
At 11 years old, Jaheim Whigham (center) is the youngest and smallest patient to receive the 50cc SynCardia temporary Total Artificial Heart. (Photo: Jan Terry, Ann & Robert H. Lurie Children’s Hospital of Chicago)Continue reading
Hearst Foundation funds TGen research into cancer-related ‘wasting syndrome’
Cachexia responsible for more than 30 percent of deaths in cancer patients
SenesTech is Ramping Things Up
SenesTech, Inc. (SNES), a developer of proprietary technologies for managing animal pest populations through fertility control is ramping up manufacturing capabilities to meet demand in 2017 and beyond for the company’s innovative new rodent control technology, ContraPest. The Company’s existing manufacturing capacity, estimated at 300,000 liters per year, is expected to double under the current expansion plans.Continue reading